Literature DB >> 4282504

[The enzyme defect in recessive congenital methemoglobinemia with encephalopathy. A new defective variant of NADH-diaphorase (Beni-Messous variant)].

J C Kaplan, A Leroux, S Bakouri, J P Grangaud, M Benabadji.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4282504

Source DB:  PubMed          Journal:  Nouv Rev Fr Hematol        ISSN： 0029-4810


× No keyword cloud information.
  7 in total

1.  [Immunological studies on glucosephosphate isomerase deficiency: instability and impaired synthesis of the defective enzyme (author's transl)].

Authors:  H Arnold; M Seiberling; K G Blume; G W Löhr
Journal:  Klin Wochenschr       Date:  1975-12-01

Review 2.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

3.  Quantitative variations of red-cell cytochrome b5 reductase (NADH-methemoglobin-reductase) in the Algerian population: evidence for defective alleles.

Authors:  A Reghis; M Benabadji; P Tchen; J C Kaplan
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

4.  Membrane-bound cytochrome b5 reductase (methemoglobin reductase) in human erythrocytes. Study in normal and methemoglobinemic subjects.

Authors:  D Choury; A Leroux; J C Kaplan
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

5.  Molecular mechanism of erythrocyte pyruvate kinase deficiency.

Authors:  A Kahn; J Marie; C Galand; P Boivin
Journal:  Humangenetik       Date:  1975-10-07

6.  Lipids of myelin, white matter and gray matter in a case of generalized deficiency of cytochrome b5 reductase in congenital methemoglobinemia with mental retardation.

Authors:  H Hirono
Journal:  Lipids       Date:  1980-04       Impact factor: 1.880

7.  NADH cytochrome b5 reductase activity in lymphoid cell lines. Expression of the defect in epstein Barr virus transformed lymphoblastoid cell lines from patients with recessive congenital methemoglobinemia.

Authors:  D Lostanlen; G Lenoir; J C Kaplan
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.